Ultrasensitive profiling of UV-induced mutations identifies thousands of subclinical facial tumors in tuberous sclerosis complex

Background Tuberous sclerosis complex (TSC) is a neurogenetic syndrome due to loss-of-function mutations in TSC2 or TSC1, characterized by tumors at multiple body sites, including facial angiofibroma (FAF). Here, an ultrasensitive assessment of the extent and range of UV-induced mutations in TSC fac...

Full description

Bibliographic Details
Main Authors: Katarzyna Klonowska, Joannes M. Grevelink, Krinio Giannikou, Barbara A. Ogorek, Zachary T. Herbert, Aaron R. Thorner, Thomas N. Darling, Joel Moss, David J. Kwiatkowski
Format: Article
Language:English
Published: American Society for Clinical Investigation 2022-05-01
Series:The Journal of Clinical Investigation
Subjects:
Online Access:https://doi.org/10.1172/JCI155858
_version_ 1811237938482118656
author Katarzyna Klonowska
Joannes M. Grevelink
Krinio Giannikou
Barbara A. Ogorek
Zachary T. Herbert
Aaron R. Thorner
Thomas N. Darling
Joel Moss
David J. Kwiatkowski
author_facet Katarzyna Klonowska
Joannes M. Grevelink
Krinio Giannikou
Barbara A. Ogorek
Zachary T. Herbert
Aaron R. Thorner
Thomas N. Darling
Joel Moss
David J. Kwiatkowski
author_sort Katarzyna Klonowska
collection DOAJ
description Background Tuberous sclerosis complex (TSC) is a neurogenetic syndrome due to loss-of-function mutations in TSC2 or TSC1, characterized by tumors at multiple body sites, including facial angiofibroma (FAF). Here, an ultrasensitive assessment of the extent and range of UV-induced mutations in TSC facial skin was performed.Methods A multiplex high-sensitivity PCR assay (MHPA) was developed, enabling mutation detection at extremely low (<0.1%) variant allele frequencies (VAFs).Results MHPA assays were developed for both TSC2 and TP53, and applied to 81 samples, including 66 skin biopsies. UV-induced second-hit mutation causing inactivation of TSC2 was pervasive in TSC facial skin with an average of 4.8 mutations per 2-mm biopsy at median VAF 0.08%, generating more than 150,000 incipient facial tumors (subclinical “micro-FAFs”) in the average TSC subject. The MHPA analysis also led to the identification of a refined UV-related indel signature and a recurrent complex mutation pattern, consisting of both a single-nucleotide or dinucleotide variant and a 1- to 9-nucleotide deletion, in cis.Conclusion TSC facial skin can be viewed as harboring a patchwork of clonal fibroblast proliferations (micro-FAFs) with indolent growth, a small proportion of which develop into clinically observable FAF. Our observations also expand the spectrum of UV-related mutation signatures.Funding This work was supported by the TSC Alliance; the Engles Family Fund for Research in TSC and LAM; and the NIH, National Heart, Lung, and Blood Institute (U01HL131022-04 and Intramural Research Program).
first_indexed 2024-04-12T12:33:10Z
format Article
id doaj.art-702bdb854df14b3fa35510627c3d82e1
institution Directory Open Access Journal
issn 1558-8238
language English
last_indexed 2024-04-12T12:33:10Z
publishDate 2022-05-01
publisher American Society for Clinical Investigation
record_format Article
series The Journal of Clinical Investigation
spelling doaj.art-702bdb854df14b3fa35510627c3d82e12022-12-22T03:32:59ZengAmerican Society for Clinical InvestigationThe Journal of Clinical Investigation1558-82382022-05-0113210Ultrasensitive profiling of UV-induced mutations identifies thousands of subclinical facial tumors in tuberous sclerosis complexKatarzyna KlonowskaJoannes M. GrevelinkKrinio GiannikouBarbara A. OgorekZachary T. HerbertAaron R. ThornerThomas N. DarlingJoel MossDavid J. KwiatkowskiBackground Tuberous sclerosis complex (TSC) is a neurogenetic syndrome due to loss-of-function mutations in TSC2 or TSC1, characterized by tumors at multiple body sites, including facial angiofibroma (FAF). Here, an ultrasensitive assessment of the extent and range of UV-induced mutations in TSC facial skin was performed.Methods A multiplex high-sensitivity PCR assay (MHPA) was developed, enabling mutation detection at extremely low (<0.1%) variant allele frequencies (VAFs).Results MHPA assays were developed for both TSC2 and TP53, and applied to 81 samples, including 66 skin biopsies. UV-induced second-hit mutation causing inactivation of TSC2 was pervasive in TSC facial skin with an average of 4.8 mutations per 2-mm biopsy at median VAF 0.08%, generating more than 150,000 incipient facial tumors (subclinical “micro-FAFs”) in the average TSC subject. The MHPA analysis also led to the identification of a refined UV-related indel signature and a recurrent complex mutation pattern, consisting of both a single-nucleotide or dinucleotide variant and a 1- to 9-nucleotide deletion, in cis.Conclusion TSC facial skin can be viewed as harboring a patchwork of clonal fibroblast proliferations (micro-FAFs) with indolent growth, a small proportion of which develop into clinically observable FAF. Our observations also expand the spectrum of UV-related mutation signatures.Funding This work was supported by the TSC Alliance; the Engles Family Fund for Research in TSC and LAM; and the NIH, National Heart, Lung, and Blood Institute (U01HL131022-04 and Intramural Research Program).https://doi.org/10.1172/JCI155858DermatologyGenetics
spellingShingle Katarzyna Klonowska
Joannes M. Grevelink
Krinio Giannikou
Barbara A. Ogorek
Zachary T. Herbert
Aaron R. Thorner
Thomas N. Darling
Joel Moss
David J. Kwiatkowski
Ultrasensitive profiling of UV-induced mutations identifies thousands of subclinical facial tumors in tuberous sclerosis complex
The Journal of Clinical Investigation
Dermatology
Genetics
title Ultrasensitive profiling of UV-induced mutations identifies thousands of subclinical facial tumors in tuberous sclerosis complex
title_full Ultrasensitive profiling of UV-induced mutations identifies thousands of subclinical facial tumors in tuberous sclerosis complex
title_fullStr Ultrasensitive profiling of UV-induced mutations identifies thousands of subclinical facial tumors in tuberous sclerosis complex
title_full_unstemmed Ultrasensitive profiling of UV-induced mutations identifies thousands of subclinical facial tumors in tuberous sclerosis complex
title_short Ultrasensitive profiling of UV-induced mutations identifies thousands of subclinical facial tumors in tuberous sclerosis complex
title_sort ultrasensitive profiling of uv induced mutations identifies thousands of subclinical facial tumors in tuberous sclerosis complex
topic Dermatology
Genetics
url https://doi.org/10.1172/JCI155858
work_keys_str_mv AT katarzynaklonowska ultrasensitiveprofilingofuvinducedmutationsidentifiesthousandsofsubclinicalfacialtumorsintuberoussclerosiscomplex
AT joannesmgrevelink ultrasensitiveprofilingofuvinducedmutationsidentifiesthousandsofsubclinicalfacialtumorsintuberoussclerosiscomplex
AT kriniogiannikou ultrasensitiveprofilingofuvinducedmutationsidentifiesthousandsofsubclinicalfacialtumorsintuberoussclerosiscomplex
AT barbaraaogorek ultrasensitiveprofilingofuvinducedmutationsidentifiesthousandsofsubclinicalfacialtumorsintuberoussclerosiscomplex
AT zacharytherbert ultrasensitiveprofilingofuvinducedmutationsidentifiesthousandsofsubclinicalfacialtumorsintuberoussclerosiscomplex
AT aaronrthorner ultrasensitiveprofilingofuvinducedmutationsidentifiesthousandsofsubclinicalfacialtumorsintuberoussclerosiscomplex
AT thomasndarling ultrasensitiveprofilingofuvinducedmutationsidentifiesthousandsofsubclinicalfacialtumorsintuberoussclerosiscomplex
AT joelmoss ultrasensitiveprofilingofuvinducedmutationsidentifiesthousandsofsubclinicalfacialtumorsintuberoussclerosiscomplex
AT davidjkwiatkowski ultrasensitiveprofilingofuvinducedmutationsidentifiesthousandsofsubclinicalfacialtumorsintuberoussclerosiscomplex